Form 4 for IMNM Immunome Inc.
Accepted 2021-08-20 00:00:00 ET · period of report 2021-08-18 · accession 0001104659-21-108267 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-20 | 2021-08-18 | IMNM | BARON RICHARD A | Dir | M - OptEx | $11.38 | +2,343 | 2,343 | New | +$26.7K |
| D | 2021-08-20 | 2021-08-18 | IMNM | BARON RICHARD A | Dir | M - OptEx | $0.00 | -2,343 | 5,157 | -31% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-18 | M | A | 2,343 | $11.38 | 2,343 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-08-18 | M | D | 2,343 | $0.00 | 5,157 | D | $11.38 · — to 2030-11-03 | 2,343 Common Stock | (F1) The shares subject to the option vest/vested one-twelfth (1/12th) on February 3, 2021, and one-twelfth (1/12th) every three months thereafter. |